Home/Filings/4/0001641172-25-001922
4//SEC Filing

Seshadri Vishwas 4

Accession 0001641172-25-001922

CIK 0000318306other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 7:17 PM ET

Size

5.5 KB

Accession

0001641172-25-001922

Insider Transaction Report

Form 4
Period: 2025-03-31
Seshadri Vishwas
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-03-31$4.78/sh25,000$119,5001,355,322 total
Footnotes (2)
  • [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024.
  • [F2]Weighted average price. These shares were sold in multiple transactions at prices ranging from $4.71 to $4.81 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Documents

1 file

Issuer

ABEONA THERAPEUTICS INC.

CIK 0000318306

Entity typeother

Related Parties

1
  • filerCIK 0001865131

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 7:17 PM ET
Size
5.5 KB